Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
09/2013
09/18/2013EP2638017A1 Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
09/18/2013EP2638016A1 Process for the preparation of 3-(6-amino-pyridin-3yl)-2-acrylic acid derivatives
09/18/2013CN103313707A Diphenyl-amine derivatives: uses, process of synthesis and pharmaceutical compositions
09/18/2013CN103304516A Method for preparing beta-aminoketone, ester and nitrile amide derivatives
09/18/2013CN103304482A Multi-nitrobenzene substituted nitroimidazole energetic compound and preparation method thereof
09/18/2013CN103304481A Preparation method of low-temperature oxygen bleaching activator as well as scouring and bleaching formula and method thereof
09/18/2013CN102603619B Compound with anticancer activity and preparation method thereof
09/17/2013US8536157 Non-steroidal compounds
09/17/2013CA2669503C Compounds and methods for thiol-containing compound efflux and cancer treatment
09/17/2013CA2521883C Indene derivatives as pharmaceutical agents
09/12/2013US20130237705 Method for manufacture of 2-oxoimidazolidines
09/12/2013US20130237702 Alkylamine derivative
09/12/2013US20130237552 Sulfur derivatives as chemokine receptor modulators
09/12/2013DE102012004490A1 Enriching a concentration and/or recovery of an ionic liquid of a mixture containing ionic liquid and an aqueous or organic solvent, comprises partially separating non-ionic liquid from the mixture by spray drying process
09/12/2013DE102010040822B4 Neue Imidazoliumsalze und darauf basierende Carben-Metallkomplexe zur Verwendung als bioanalytische Marker für Biomoleküle New imidazolium and based thereon carbene metal complexes for use as bioanalytical markers for biomolecules
09/11/2013CN103288742A Preparation method for high-purity ingavirin raw material
09/11/2013CN103288741A Histamine hapten, artificial antigen, antibody, as well as preparation methods and applications thereof
09/11/2013CN103288740A Preparation method of high-purity isoconeazole nitrate
09/11/2013CN103288739A Complex of heteropoly tungstic acid anions and alkyl imidazolium cations and preparation method
09/11/2013CN103288702A Method for preparing atorvastatin amino acid salt
09/11/2013CN101959882B 咪唑羰基化合物 Imidazole-carbonyl compound
09/10/2013US8530671 Method for preparing a material formed from arborescent-branched molecules comprising associative groups
09/10/2013US8530480 Substituted pyrimidinyl-amines as protein kinase inhibitors
09/10/2013US8530461 Azetidine derivatives
09/10/2013CA2700690C Process for producing reformatsky reagent in stable form
09/06/2013WO2013128421A1 Spirohydantoin compounds and their use as selective androgen receptor modulators
09/05/2013US20130231323 Ethynylbenzene derivatives
09/05/2013US20130230501 Cycloalkyl-Substituted Imidazole Derivative
09/04/2013CN103275675A Application of ionic liquid material serving as cross-seasonal phase change heat storage material
09/04/2013CN103275014A Compound containing pentazole ring bisazo structure, as well as preparation method and application thereof
09/04/2013CN103275013A Novel nitrogenous heterocycle sulfamide derivative type aromatizing enzyme inhibitor and preparation method thereof
09/04/2013CN103275012A Preparation method and application of Maca alkaloid
09/04/2013CN103275011A Novel method for synthesizing imidazolidine heterocycle
09/04/2013CN103274985A Atorvastatin amino acid salts
09/04/2013CN103274953A Naphthol and o-naphthoquinone compounds thereof and preparation method and medical application thereof
09/04/2013CN102415387B Surface active ionic liquid bactericide and application thereof in sterilization of oilfield injection water
09/04/2013CN102276439B Method for preparing fatty acid radical ionic liquid
09/03/2013US8524755 Specific diarylhydantoin and diarylthiohydantoin compounds
08/2013
08/29/2013US20130225832 Process for the resolution of medetomidine and recovery of the unwanted enantiomer
08/29/2013US20130225621 Substituted 2-hydroxy-4-(2-(phenylsulfonamido)acetamido)benzoic acid analogs as inhibitors of stat protein
08/29/2013US20130225587 Compound for increasing kinase active and application thereof
08/28/2013CN1538951B Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of chemotaxis of polymorphonucleate and mononucleate cells
08/28/2013CN103265560A Gossypol/ cotton ketone derivative and preparation method thereof and application of derivative in anti-tumor medicament
08/28/2013CN103265494A Nitroimidazole energetic compound and preparation method thereof
08/28/2013CN103265493A Desmodium sequax extractive, as well as extraction method and new application thereof
08/28/2013CN103265492A Chlorinated 1-vinyl-3-carboxymethyl imidazole polymerizable acidic ionic liquid and synthetic method thereof
08/28/2013CN102190625B Stilbene tumor targeted medicine Combretastatin A4 analogs
08/28/2013CN101248049B 咪唑类lxr调节剂 Imidazole lxr modifier
08/28/2013CN101248048B Imidazole based LXR modulators
08/27/2013US8518999 Modulators of TNF-αsignaling
08/27/2013US8518968 Hydrazone and diacyl hydrazine compounds and methods of use
08/27/2013CA2731215C Imidazole carboxamide derivatives and their use in treatment of conditions associated with the mglur2 receptor
08/22/2013WO2013122953A1 Imidazolidine-2,4-dione derivatives as n-formyl peptide receptor 2 modulators
08/22/2013WO2013120771A1 Imidazolylketone derivatives asd aldosterone synthase inhibitors
08/22/2013US20130217740 Metronidazole esters for treating rosacea
08/22/2013US20130217739 Therapeutic compounds
08/22/2013US20130217732 Selective Androgen Receptor Modulators
08/22/2013US20130217720 Imidazolidine-2,4-dione derivatives as n-formyl peptide receptor 2 modulators
08/22/2013US20130217660 Novel prolylcarboxypeptidase inhibitors
08/22/2013US20130217632 Non-Natural Amino Acids
08/22/2013DE102012101248A1 Acylhydrazone und ihre Verwendung zur Vermeidung der Ausbildung oder zur Aufhebung von Resistenzen von Tumoren gegen Zytostatika Acylhydrazones and their use to avoid the formation or to the annulment of resistance of tumors to cytotoxic drugs
08/21/2013EP2628727A2 Biaryl PDE4 inhibitors for treating pulmonary and cardiovascular disorders
08/21/2013CN103261185A Continuous arycyclic compound
08/21/2013CN103261169A Deubiquitinase inhibitors and methods for use of the same
08/21/2013CN103261164A Neprilysin inhibitors
08/21/2013CN103254136A Method for preparing quadri [4-(1- imidazolyl) phenyl] methane
08/21/2013CN103254135A Imidazolium ionic liquid and preparation method for single crystal thereof
08/21/2013CN103254134A Synthetic method of polysubstituted imidazoles
08/21/2013CN103254053A Alpha-fluoro-chalcone type compound and preparation and application thereof
08/21/2013CN102046599B Use of ionic liquids with tetracyanoborate anions as a solvent for extraction of alcohols from aqueous solutions
08/21/2013CN101723976B Ionic liquids comprising fluoralkyltriffluoroborate anions
08/20/2013US8513435 Method for preparing aminoethyl imidazolidinone or the thiocarbonyl thereof
08/20/2013US8513294 Substituted imidazole derivatives and methods of use thereof for treating cancer
08/20/2013US8513253 α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
08/20/2013US8512675 N and/or Nα derivatized, metal and organic protected L-histidine for coupling to biomolecules for highly efficient labeling with [M(OH2)3 (CO)3]+ by fac coordination
08/20/2013US8512534 Redox polymers
08/15/2013US20130211079 Substituted heterocycles as therapeutic agents for treating cancer
08/15/2013US20130211057 Molecules having combinable groups
08/15/2013US20130210848 New salt of a pyrimidin derivative
08/15/2013US20130210847 Process for the preparation of nilotinib
08/15/2013US20130210769 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
08/14/2013EP2626349A1 Amine compound and use for same
08/14/2013CN103242235A Chloridized 1-vinyl-3-amino-formyl methyl-imidazole bifunctional ionic liquid and synthetic method thereof
08/14/2013CN103242192A Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
08/14/2013CN102424663B Atorvastatin amino acid and preparation method thereof
08/14/2013CN102171382B 2-benzyl-4-(2,4-dichlorophenyl)-5-methylimidazole compound
08/13/2013US8507692 Ester compound and use thereof
08/08/2013WO2013116715A1 Methods and intermediates for preparing pharmaceutical agents
08/08/2013WO2013113319A1 Process for the preparation of strontium ranelate, intermediate or hydrates thereof
08/08/2013US20130203830 Compounds for Prevention of Cell Injury
08/08/2013US20130203829 Mitochondria-Targeted Inhibitors of Cytochrome C Peroxidase for Protection from Apoptosis
08/08/2013DE112007000484B4 Stabil isotopenmarkierte aliphatische Aminosäuren, Verfahren zum Einbringen von diesen in ein Zielprotein und Verfahren zur NMR-Konformationsanalyse von Proteinen Stable isotope-labeled aliphatic amino acids, methods for introducing these into a target protein, and NMR method for the conformation of proteins
08/07/2013EP2621934A1 Electrolyte formulations containing cyano-alkoxy-borate anions
08/07/2013EP2621907A1 Fungicidal imidazoles
08/07/2013EP2621901A1 Selective androgen receptor modulators
08/07/2013CN103237853A The use of aryl or heteroaryl substituted dithiolene metal complexes as ir absorbers
08/07/2013CN103237788A Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
08/07/2013CN103232398A Rosuvastatin amino acid salt as well as preparation method and application thereof
08/07/2013CN103232396A Three selective ionic liquids and synthesizing method thereof
08/07/2013CN103232395A Sodium ozagrel compound, preparation method and drug composition thereof
1 ... 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ... 345